La fertilización in vitro (FIV) ha sido un faro de esperanza para millones de parejas en todo el mundo que luchan contra la infertilidad. Desde su inicio en la década de 1970, esta técnica ha evolucionado considerablemente, y hoy en día, los avances científicos est …
El Monte Everest, la cumbre más alta del mundo, ha cautivado la imaginación de aventureros y exploradores durante siglos. Los primeros ascensos a esta icónica montaña representan hazañas de valor, determinación y exploración que han dejado una huella …
Sandoz, the global leader in generic and biosimilar medicines, announced that the European Commission has granted marketing authorization for Wyost®1 and Jubbonti®2, the first and only biosimilar versions of reference medicines Xgeva®*3 and Prolia®*4 in Europe.
OSE Immunotherapeutics SA and Boehringer Ingelheim announced a major expansion of their partnership.
Arbutus Biopharma Corporation announced that two abstracts have been accepted for poster and oral presentations at the European Association for the Study of the Liver Congress 2024 taking place June 5 – 8, 2024 in Milan, Italy.
Arbutus to Present Imdusiran Data at EASL Congress 2024 Read More »
NANOBIOTIX provided an update on operational progress and reported financial results for the first quarter of 2024.
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update Read More »
Dyne Therapeutics, Inc., a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock at a public offering price of $31.00 per share.
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock Read More »
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the agreed outcome of the “Day 100” meetingi with the US Food and Drug Administration, following receipt of the “Day 90” major deficiency Letter.
Evotec SE announced financial results and corporate updates for the first quarter 2024.
Evotec Reports Q1 2024 Results and Provides Corporate Update Read More »
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company’s annual general meeting will be broadcast live on YouTube.
IRLAB broadcasts the Annual General Meeting Live – May 22, 2024 Read More »
